Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00866957 · ClinicalTrials.gov registry record
Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)
A clinical trial of Liver Cancer, sponsored by Northwestern University.
- Completed
- Registry status
- 180
- Enrollment target
- 1
- Study location
NCT00866957: Completed study of Liver Cancer, sponsored by Northwestern University.
NCT00866957 is a study of Liver Cancer that has completed, run by Northwestern University. The registered enrollment target is 180 participants, below the 446-participant average among 78 other Liver Cancer trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00866957, a study of Liver Cancer, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare levels of HIF-1 α (Hypoxia Inducing Factor 1-alpha) in patients who have been treated with various types of liver cancer treatments.
Primary Outcome
The primary objective is to compare levels of HIF-1alpha expression in HCC tumor explants which have received: 1) no pre-explant embolization; 2) pre-explant Transcatheter arterial chemoembolization (TACE); 3) pre-explant Y90 radio-embolization; 4) pre-explant radiofrequency ablation, or 5) a combination of pre-explant therapies.
Conditions Studied
Interventions
- PROCEDURE Blood draw
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2006-02 |
| Est. Completion | 2019-07 |
What the finished NCT00866957 record still lists
NCT00866957 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 78 other Liver Cancer trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT00866957 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00866957 about?
NCT00866957 is a clinical study titled "Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)". The purpose of the study is to compare levels of HIF-1 α (Hypoxia Inducing Factor 1-alpha) in patients who have been treated with various types of liver cancer treatments.
What is the current status of trial NCT00866957?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2006-02. Estimated completion is 2019-07.
What conditions does trial NCT00866957 study?
This clinical trial studies the following conditions: Liver Cancer.
What interventions are being tested in trial NCT00866957?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT00866957?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00866957 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00866957's enrollment target sits among peer trials
180 19th of 78 higher than 60 of 78 other Liver Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia